Marker Therapeutics (MRKR) Short Interest Ratio & Short Volume $1.25 +0.06 (+5.02%) Closing price 05/2/2025 03:59 PM EasternExtended Trading$1.26 +0.01 (+0.48%) As of 05/2/2025 05:03 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock Marker Therapeutics Short Interest DataMarker Therapeutics (MRKR) has a short interest of 197,200 shares, representing 2.64% of the float (the number of shares available for trading by the public). This marks a -50.70% decrease in short interest from the previous month. The short interest ratio (days to cover) is 1.6, indicating that it would take 1.6 days of the average trading volume of 61,667 shares to cover all short positions.Current Short Interest197,200 sharesPrevious Short Interest400,000 sharesChange Vs. Previous Month-50.70%Dollar Volume Sold Short$230,724.00Short Interest Ratio1.6 Days to CoverLast Record DateApril 15, 2025Outstanding Shares11,315,000 sharesFloat Size7,470,000 sharesShort Percent of Float2.64%Today's Trading Volume87,132 sharesAverage Trading Volume61,667 sharesToday's Volume Vs. Average141% Short Selling Marker Therapeutics? Sign up to receive the latest short interest report for Marker Therapeutics and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartMRKR Short Interest Over TimeMRKR Days to Cover Over TimeMRKR Percentage of Float Shorted Over Time Marker Therapeutics Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/15/2025197,200 shares $230,724.00 -50.7%2.6%1.6 $1.17 3/31/2025400,000 shares $492,000.00 +7.4%5.4%3.1 $1.23 3/15/2025372,500 shares $460,037.50 +170.1%5.0%2.9 $1.24 2/28/2025137,900 shares $210,987.00 -7.9%1.9%1 $1.53 2/15/2025149,800 shares $257,656.00 -35.5%2.1%1.9 $1.72 1/31/2025232,100 shares $427,064.00 +20.0%3.0%3.2 $1.84 1/15/2025193,400 shares $531,850.00 +74.6%2.5%3.1 $2.75 12/31/2024110,800 shares $344,588.00 +32.5%1.6%1.8 $3.11 12/15/202483,600 shares $340,252.00 +66.9%1.3%1.5 $4.07 11/30/202450,100 shares $175,350.00 -12.1%0.8%1.4 $3.50 Get the Latest News and Ratings for MRKR and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Marker Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 11/15/202457,000 shares $174,990.00 -18.6%0.9%1.6 $3.07 10/31/202470,000 shares $283,500.00 +14.2%1.1%1.9 $4.05 10/15/202461,300 shares $200,451.00 +9.9%1.0%1.7 $3.27 9/30/202455,800 shares $157,356.00 -13.9%0.9%2.2 $2.82 9/15/202464,800 shares $179,781.12 -22.7%1.0%2.4 $2.77 8/31/202483,800 shares $302,518.00 +3.3%1.3%2.7 $3.61 8/15/202481,100 shares $257,898.00 -17.8%1.3%3 $3.18 7/31/202498,600 shares $482,154.00 -2.2%1.5%4.4 $4.89 7/15/2024100,800 shares $561,456.00 -14.0%1.6%4.7 $5.57 6/30/2024117,200 shares $636,396.00 +25.6%1.8%5.9 $5.43 6/15/202493,300 shares $388,566.51 +58.1%1.5%4.6 $4.16 5/31/202459,000 shares $228,330.00 +17.1%0.9%3.5 $3.87 5/15/202450,400 shares $210,168.00 -6.5%0.8%3 $4.17 4/30/202453,900 shares $218,295.00 -16.3%0.8%3 $4.05 4/15/202464,400 shares $285,936.00 -40.3%1.0%3.4 $4.44 3/31/2024107,900 shares $463,970.00 -27.9%1.7%5.1 $4.30 3/15/2024149,700 shares $663,171.00 -7.0%2.3%6 $4.43 2/29/2024160,900 shares $584,067.00 -9.6%2.5%2 $3.63 2/15/2024177,900 shares $752,517.00 +1.1%2.8%2.2 $4.23 1/31/2024175,900 shares $816,176.00 -12.7%2.7%2.2 $4.64 1/15/2024201,400 shares $970,748.00 -14.5%3.1%2.5 $4.82 12/31/2023235,500 shares $1.30 million -10.9%3.7%2.9 $5.50 12/15/2023264,300 shares $1.24 million +56.0%4.1%3.3 $4.70 11/30/2023169,400 shares $467,544.00 -18.1%2.7%2.3 $2.76 11/15/2023206,900 shares $577,251.00 -3.9%3.2%5.6 $2.79 10/31/2023215,200 shares $516,480.00 -7.8%3.4%4.6 $2.40 10/15/2023233,400 shares $772,554.00 -10.0%3.7%2.7 $3.31 9/30/2023259,200 shares $1.18 million -16.5%4.1%2.2 $4.54 9/15/2023310,300 shares $1.66 million +65.8%4.9%2.2 $5.36 8/31/2023187,200 shares $1.05 million -11.3%3.0%0.9 $5.62Elon’s Terrifying Warning Forces Trump To Take Action (Ad)Elon Musk has avoided two major financial crises before. He pulled Tesla and SpaceX back from the brink of collapse and built two of the most valuable companies in history. Now, he's sounding the alarm about America's $36 trillion debt time bomb that could destroy the fabric of our society.As head of the Department of Government Efficiency (DOGE) under President Trump, Musk is exposing just how bad things are...Get your free gold guide! 8/15/2023211,000 shares $1.24 million -23.1%3.3%0.3 $5.86 7/31/2023274,200 shares $1.38 million +43.3%4.4%0.3 $5.05 7/15/2023191,300 shares $1.01 million -41.1%3.0%0.2 $5.26 6/30/2023325,000 shares $1.01 million -28.8%5.2%0.4 $3.10 6/15/2023456,500 shares $1.13 million +478.6%7.2%0.6 $2.48 5/31/202378,900 shares $140,442.00 -26.3%1.3%0.1 $1.78 5/15/2023107,000 shares $146,590.00 -51.0%1.7%0.8 $1.37 4/30/2023218,400 shares $183,761.76 +1,169.8%3.0%1.6 $0.84 4/15/202317,200 shares $18,920.00 +91.1%0.2%0.2 $1.10 3/31/20239,000 shares $6,390.00 -90.0%0.1%0.2 $0.71 3/15/202389,900 shares $178,002.00 +37.5%1.2%1.7 $1.98 2/28/202365,400 shares $141,918.00 +64.3%0.9%1.7 $2.17 2/15/202339,800 shares $89,948.00 -18.3%0.6%1 $2.26 1/31/202348,700 shares $136,360.00 -93.7%0.8%1.2 $2.80 1/15/2023767,400 shares $272,503.74 +30.8%1.2%2.6 $0.36 12/30/2022586,600 shares $155,976.35 -21.4%1.0%1.9 $0.27 12/15/2022745,800 shares $222,621.30 -11.6%1.3%2.7 $0.30 11/30/2022843,800 shares $253,140.00 -14.7%1.4%2.5 $0.30 11/15/2022989,100 shares $343,514.43 -16.9%1.7%2 $0.35 10/31/20221,190,000 shares $528,003.00 +21.5%2.0%2.2 $0.44 10/15/2022979,200 shares $381,888.00 -16.3%1.7%0.5 $0.39 9/30/20221,170,000 shares $431,496.00 -6.4%4.3%0.6 $0.37 9/15/20221,250,000 shares $573,125.00 -9.4%4.6%0.6 $0.46 8/31/20221,380,000 shares $427,800.00 -14.3%5.1%0.7 $0.31 8/15/20221,610,000 shares $643,034.00 +87.8%5.9%0.9 $0.40 7/31/2022857,100 shares $273,414.90 -23.5%3.1%0.5 $0.32 7/15/20221,120,000 shares $374,080.00 +6.7%4.1%4.1 $0.33 6/30/20221,050,000 shares $346,500.00 -13.2%3.9%3.5 $0.33 6/15/20221,210,000 shares $326,700.00 -8.3%4.4%3.9 $0.27 5/31/20221,320,000 shares $398,640.00 -10.2%2.3%3.9 $0.30 5/15/20221,470,000 shares $484,218.00 No Change2.6%3.7 $0.33 4/30/20221,470,000 shares $498,330.00 -2.7%2.6%3.2 $0.34 4/15/20221,510,000 shares $610,040.00 +24.8%2.7%2.9 $0.40 3/31/20221,210,000 shares $532,400.00 -42.1%2.2%1.7 $0.44 3/15/20222,090,000 shares $836,000.00 +26.7%3.7%2.8 $0.40 2/28/20221,650,000 shares $620,565.00 +3.8%2.9%2.2 $0.38 2/15/20221,590,000 shares $935,397.00 -7.6%2.8%2.1 $0.59 1/31/20221,720,000 shares $1.04 million +84.6%3.0%2.4 $0.61 1/15/2022931,700 shares $753,093.11 -9.5%1.7%1.4 $0.81 12/31/20211,030,000 shares $978,500.00 +6.3%1.8%2.4 $0.95 12/15/2021968,900 shares $968,900.00 -14.3%1.7%2.3 $1.00 11/30/20211,130,000 shares $1.33 million No Change2.0%3 $1.18 11/15/20211,130,000 shares $1.58 million -5.0%2.0%3.4 $1.40 10/29/20211,190,000 shares $1.75 million No Change2.1%2.6 $1.47 10/15/20211,190,000 shares $1.89 million -8.5%2.1%2.5 $1.59 9/30/20211,300,000 shares $2.20 million -3.7%2.3%2.6 $1.69 9/15/20211,350,000 shares $2.46 million -3.6%2.4%2.2 $1.82 8/31/20211,400,000 shares $2.77 million -3.5%2.5%1.9 $1.98 8/13/20211,450,000 shares $2.77 million -1.4%2.6%1.5 $1.91 7/30/20211,470,000 shares $3.07 million +52.3%2.6%1.3 $2.09Elon’s Terrifying Warning Forces Trump To Take Action (Ad)Elon Musk has avoided two major financial crises before. He pulled Tesla and SpaceX back from the brink of collapse and built two of the most valuable companies in history. Now, he's sounding the alarm about America's $36 trillion debt time bomb that could destroy the fabric of our society.As head of the Department of Government Efficiency (DOGE) under President Trump, Musk is exposing just how bad things are...Get your free gold guide! 7/15/2021965,500 shares $2.12 million -21.5%1.7%0.7 $2.20 6/30/20211,230,000 shares $3.43 million -47.0%2.2%0.8 $2.79 6/15/20212,320,000 shares $7.48 million -2.5%4.1%1.2 $3.23 5/28/20212,380,000 shares $6.93 million -11.5%4.2%0.6 $2.91 5/14/20212,690,000 shares $5.60 million -6.9%4.8%0.7 $2.08 4/30/20212,890,000 shares $7.75 million -7.4%5.2%0.8 $2.68 4/15/20213,120,000 shares $6.61 million -5.2%5.9%0.9 $2.12 3/31/20213,290,000 shares $7.11 million -5.7%9.2%1 $2.16 3/15/20213,490,000 shares $6.77 million +7.4%9.9%1.2 $1.94 2/26/20213,250,000 shares $8.00 million -3.9%10.0%5.5 $2.46 2/12/20213,380,000 shares $10.34 million +5.3%10.4%5.9 $3.06 1/29/20213,210,000 shares $5.78 million -4.5%9.8%6 $1.80 1/15/20213,360,000 shares $7.16 million No Change10.3%7.9 $2.13 MRKR Short Interest - Frequently Asked Questions What is Marker Therapeutics' current short interest? Short interest is the volume of Marker Therapeutics shares that have been sold short but have not yet been covered or closed out. As of April 15th, investors have sold 197,200 shares of MRKR short. 2.64% of Marker Therapeutics' shares are currently sold short. Learn More on Marker Therapeutics' current short interest. What is a good short interest ratio for Marker Therapeutics? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. MRKR shares currently have a short interest ratio of 2.0. Learn More on Marker Therapeutics's short interest ratio. Which institutional investors are shorting Marker Therapeutics? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Marker Therapeutics: Concourse Financial Group Securities Inc.. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. What is a good short interest percentage for Marker Therapeutics? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 2.64% of Marker Therapeutics' floating shares are currently sold short. Is Marker Therapeutics' short interest increasing or decreasing? Marker Therapeutics saw a drop in short interest during the month of April. As of April 15th, there was short interest totaling 197,200 shares, a drop of 50.7% from the previous total of 400,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Marker Therapeutics' float size? Marker Therapeutics currently has issued a total of 11,315,000 shares. Some of Marker Therapeutics' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Marker Therapeutics currently has a public float of 7,470,000 shares. How does Marker Therapeutics' short interest compare to its competitors? 2.64% of Marker Therapeutics' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Marker Therapeutics: Kronos Bio, Inc. (1.71%), Precision BioSciences, Inc. (21.96%), Immix Biopharma, Inc. (1.16%), OKYO Pharma Limited (0.63%), PepGen Inc. (10.13%), Immuneering Co. (2.97%), Karyopharm Therapeutics Inc. (23.11%), PMV Pharmaceuticals, Inc. (1.91%), Avalo Therapeutics, Inc. (1.18%), Prelude Therapeutics Incorporated (8.32%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Invesco QQQ ($21.71 billion), iShares 20+ Year Treasury Bond ETF ($9.48 billion), Strategy Incorporated ($8.92 billion), Charter Communications, Inc. ($3.86 billion), Apollo Global Management, Inc. ($3.86 billion), Capital One Financial Co. ($3.72 billion), Super Micro Computer, Inc. ($3.47 billion), AppLovin Co. ($2.64 billion), VanEck Semiconductor ETF ($2.46 billion), and The Kroger Co. ($2.33 billion). View all of the most shorted stocks. What does it mean to sell short Marker Therapeutics stock? Short selling MRKR is an investing strategy that aims to generate trading profit from Marker Therapeutics as its price is falling. MRKR shares are trading up $0.06 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Marker Therapeutics? A short squeeze for Marker Therapeutics occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of MRKR, which in turn drives the price of the stock up even further. How often is Marker Therapeutics' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including MRKR, twice per month. The most recent reporting period available is April, 15 2025. More Short Interest Resources from MarketBeat Related Companies KRON Short Squeeze DTIL Short Squeeze IMMX Short Squeeze OKYO Short Squeeze PEPG Short Squeeze IMRX Short Squeeze KPTI Short Squeeze PMVP Short Squeeze AVTX Short Squeeze PRLD Short Squeeze Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:MRKR) was last updated on 5/4/2025 by MarketBeat.com Staff From Our PartnersWarning: “DOGE Collapse” imminentElon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week...Altimetry | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredTrump to redistribute trillions of dollars Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | Sponsored"I'm risking my reputation on this"I've stayed quiet for too long, but after everything I've uncovered about what's brewing in the 2025 crypto ma...Crypto 101 Media | SponsoredIf you missed your chance with Tesla...Elon Musk is moments from launching a revolutionary technology some Silicon Valley insiders are calling "The F...Brownstone Research | SponsoredShocking AI play that’s beats Nvidia by a country mileYou’ve seen the headlines about Nvidia. Now Tim Sykes is sounding the alarm — because what CEO Jensen Huang is...Timothy Sykes | SponsoredWill May start the next "Great Depression?"You probably haven't heard about this yet... But this could be the biggest wealth building opportunity of t...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Marker Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Marker Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy MRKR Stock Free MRKR Stock Alerts